Sign Out
Hypersensitivity to the active substances or to any of the excipients listed in Description or hypersensitivity to a previous dose of Qdenga.
Individuals with congenital or acquired immune deficiency, including immunosuppressive therapies such as chemotherapy or high doses of systemic corticosteroids (e.g. 20 mg/day or 2 mg/kg body weight/day of prednisone for 2 weeks or more) within 4 weeks prior to vaccination, as with other live attenuated vaccines.
Individuals with symptomatic HIV infection or with asymptomatic HIV infection when accompanied by evidence of impaired immune function.
Pregnant women (see Use in Pregnancy & Lactation).
Breast-feeding women (see Use in Pregnancy & Lactation).
Continue with Google